<?xml version="1.0" encoding="UTF-8"?>
<p>Dengue virus (DENV) has four serotypes, each of them can be responsible for dengue epidemics and can also be associated with severe disease depending on the sequence and time between infections, among other factors [
 <xref rid="pntd.0006847.ref004" ref-type="bibr">4</xref>â€“
 <xref rid="pntd.0006847.ref006" ref-type="bibr">6</xref>]. The clinical spectrum of dengue ranges from asymptomatic infections to life-threatening severe disease; approximately 50% to 90% of dengue infections are asymptomatic [
 <xref rid="pntd.0006847.ref007" ref-type="bibr">7</xref>, 
 <xref rid="pntd.0006847.ref008" ref-type="bibr">8</xref>]. The probability of symptomatic dengue due to dengue virus infection is altered by the previous dengue immune status [
 <xref rid="pntd.0006847.ref009" ref-type="bibr">9</xref>]. Currently there is no specific treatment for dengue infection or clinical predictors to prevent severe disease [
 <xref rid="pntd.0006847.ref010" ref-type="bibr">10</xref>].
</p>
